Radiation necrosis with stereotactic radiosurgery combined with CTLA-4 blockade and PD-1 inhibition for treatment of intracranial disease in metastatic melanoma

Timing and type of immune checkpoint therapy affect the early radiographic response of melanoma brain metastases to stereotactic radiosurgery

(2016) Jack M. Qian et al.   CANCER

Effect of Radiosurgery Alone vs Radiosurgery With Whole Brain Radiation Therapy on Cognitive Function in Patients With 1 to 3 Brain Metastases

(2016) Paul D. Brown et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Does immunotherapy increase the rate of radiation necrosis after radiosurgical treatment of brain metastases?

(2016) Rovel J. Colaco et al.   JOURNAL OF NEUROSURGERY

Pembrolizumab for patients with melanoma or non-small-cell lung cancer and untreated brain metastases: early analysis of a non-randomised, open-label, phase 2 trial

(2016) Sarah B Goldberg et al.   LANCET ONCOLOGY

BRAF inhibitor and stereotactic radiosurgery is associated with an increased risk of radiation necrosis

(2016) Kirtesh R. Patel et al.   MELANOMA RESEARCH

Initial experience with combined BRAF and MEK inhibition with stereotactic radiosurgery for BRAF mutant melanoma brain metastases

(2016) Bindiya G. Patel et al.   MELANOMA RESEARCH

Stereotactic Radiosurgery for Melanoma Brain Metastases in Patients Receiving Ipilimumab: Safety Profile and Efficacy of Combined Treatment

(2015) Ana P. Kiess et al.   INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS

Long-term risk of radionecrosis and imaging changes after stereotactic radiosurgery for brain metastases

(2015) Zachary A. Kohutek et al.   JOURNAL OF NEURO-ONCOLOGY

Adverse radiation effect after stereotactic radiosurgery for brain metastases: incidence, time course, and risk factors

(2015) Penny K. Sneed et al.   JOURNAL OF NEUROSURGERY

Ipilmumab and cranial radiation in metastatic melanoma patients: a case series and review

(2015) Jonathan D. Schoenfeld et al.   Journal for ImmunoTherapy of Cancer

Efficacy and safety of ipilimumab in patients with advanced melanoma and brain metastases

(2014) Paola Queirolo et al.   JOURNAL OF NEURO-ONCOLOGY

Survival of melanoma patients with brain metastases treated with ipilimumab and stereotactic radiosurgery

(2014) Karim Tazi et al.   Cancer Medicine

Dabrafenib in patients with Val600Glu or Val600Lys BRAF-mutant melanoma metastatic to the brain (BREAK-MB): a multicentre, open-label, phase 2 trial

(2012) Georgina V Long et al.   LANCET ONCOLOGY

Central nervous system failure in melanoma patients: results of a randomised, multicentre phase 3 study of temozolomide- and dacarbazine- based regimens

(2011) V Chiarion-Sileni et al.   BRITISH JOURNAL OF CANCER

Determinants of survival in patients with brain metastases from cutaneous melanoma

(2010) M Staudt et al.   BRITISH JOURNAL OF CANCER

Neurocognition in patients with brain metastases treated with radiosurgery or radiosurgery plus whole-brain irradiation: a randomised controlled trial

(2009) Eric L Chang et al.   LANCET ONCOLOGY